Incyte INCB054828
Update August 2018: The Incyte INCB054828 trial is no longer recruiting new patients.
A Phase 2, open-label, single-arm, multicentre international study to evaluate the efficacy and safety of the INCB054828 in patients with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma, including FGFR2 translocations, who failed previous therapy.
Incyte Corporation
ClinicalTrials.gov Identifier: NCT02924376
For more information go to: https://www.clinicaltrials.gov/ct2/show/study/NCT02924376